dr. ezanee azlina binti mohamad hanif

pensyarah universiti

institut perubatan molekul (umbi)

No. sambungan :  60391459069

No. rasmi:
UKM : 03 8921 5555
HUKM : 03-9145 6074/6075/6931/7748



   Biografi :
  • noraidatulakma abdullah, shariffah huzaimah al-junid, mee lee looi, siok fong chin, ezanee azlina mohd haniff, syed zulkifli syed zakaria, rahman jamal.  (2019).  validation of self-reported smoker and second hand smoke exposure by urinary cotinine within the malaysian cohort project.  - journal of biomedicine and translational research (jbtr).  15-22. 

     

    mohd firdaus che mat, ezanee azlina mohamad hanif, nor azian abdul murad, kamariah ibrahim, roslan harun*, rahman jamal*.  (2019).  zfp36l2 silencing increases sensitivity to temolozomide via g2m cell cycle arrest and bax mediated apoptosis.  - international health and medical sciences conference 2019.  1-54. 

     

    nor hasyimah haron, ezanee azlina mohamad hanif, mohd rizal abdul manaf, jasmi ali yaakub, roslan harun, ramelah mohamed, isa mohamed rose.  (2019).  microsatellite instability and altered expression of mlh1 and msh2 in gastric cancer.  - asian pacific journal of cancer prevention. 

     

    ezanee azlina mohamad hanif, shamsul azhar shah.  (2018).  overview on epigenetic re-programming: a potential therapeutic intervention in triple negative breast cancers.  - asian pacific journal of cancer prevention. 

     

    siok-fong chin, ezanee azlina mohamad hanif and rahman jamal.  (2018).  esmo open cancer horizons.  - protein profiling in colorectal cancer: from biological mapping to functional validation. 

     

    noraidatulakma abdullah, nor azian abdul murad, ezanee azlina mohd haniff, saiful effendi syafruddin, john attia, christopher oldmeadow, mohd arman kamaruddin, nazihah abd jalal, norliza ismail, muhiddin ishak, rahman jamal, rodney j. scott, elizabeth gh.  (2017).  predicting type 2 diabetes using genetic and environmental risk factors in a multi-ethnic malaysian cohort.  - public health.  31-38. 

     

    n abdullah, na abdul murad, j attia, c oldmeadow, ea mohd haniff, se syafruddin, n abd jalal, n ismail, m ishak, r jamal, rj scott and eg holliday.  (2015).  characterizing the genetic risk for type 2 diabetes in a malaysian multi-ethnic cohort.  - diabetic medicine.  1377-1384. 

     

    ezanee azlina mohamad hanif, shamsul azhar shah.  (2018).  overview on epigenetic re-programming: a potential therapeutic intervention in triple negative breast cancers.  - asian pacific journal of cancer prevention. 

     
    Tiada Rekod
    Tiada Rekod
    Tiada Rekod

    siti aishah sulaiman, nor azian abdul murad, ezanee azlina mohamad hanif, nadiah abu, and rahman jamal.  (2018).  circular rna: biogenesis and function.  - 370. 

     

    mohd firdaus che mat, ezanee azlina mohamad hanif, nor azian abdul murad, kamariah ibrahim, roslan harun*, rahman jamal*.  (2019).  zfp36l2 silencing increases sensitivity to temolozomide via g2m cell cycle arrest and bax mediated apoptosis.  - international health and medical sciences conference 2019.  1-54. 

     

    ezanee azlina mohamad hanif, amalia afzan saperi & paul mullan.  (2018).  setd1a regulates cell proliferation by modulating mir205 in triple negative breast cancers (tnbcs).  - 25th biennial congress of the european association for cancer research. 

     

    siok-fong chin, ezanee azlina mohamad hanif & rahman jamal.  (2018).  protein profiling in colorectal cancer: from biological mapping to functional validation.  - esmo open cancer horizons. 

     

    siok-fong chin, ezanee azlina mohamad hanif and rahman jamal.  (2017).  overexpression of leucine-rich alpha-2-glycoprotein 1 (lrg1) enhances epithelial-mesenchymal transition, cell migration and invasion in colorectal cancer.  - 7th regional conference on molecular medicine (rcmm) in conjunction with 3rd national conference for cancer research 2017. 

     

    siok-fong chin, ezanee azlina mohamad hanif & rahman jamal.  (2017).  leucine-rich alpha-2-glycoprotein 1 (lrg1) in colorectal cancer: a real potential biomarker?.  - international proteomics conference 2017.